Back to Trades
Grant4
Nutanix, Inc.
NTNX
Total Value
$0
Company Information
- Company Name
- Nutanix, Inc.
- Ticker Symbol
- NTNX
- CIK
- 0001618732
Insider Information
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Dec 16, 2025
- Transaction Date
- Dec 12, 2025
- Accession Number
- 0000950130-25-000308
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Class A Common Stock | 4,588 | — | Grant/Award | — |
Footnotes
- (F1)Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.
- (F2)The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.
- (F3)Represents 5,355,285 shares of Class A common stock held directly by BCPE Nucleon (DE) SPV, LP ("BCPE Nucleon"). The Reporting Person is a Partner of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BCPE Nucleon. Voting and investment decisions with respect to securities held by BCPE Nucleon are made by the partners of BCI. As a result, the Reporting Person may be deemed to share voting and dispositive power with respect to the securities held by BCPE Nucleon. The Reporting Person disclaims beneficial ownership of the securities held by BCPE Nucleon, except to the extent of his pecuniary interest therein.